Benessere Capital Acquisition Corp.
Benessere Capital Acquisition Corp. Fundamental Analysis
Benessere Capital Acquisition Corp. (BENEW) shows weak financial fundamentals with a PE ratio of 26.87, profit margin of 0.00%, and ROE of -486.25%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -60755.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BENEW's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBENEW demonstrates superior asset utilization.
Valuation Score
ModerateBENEW shows balanced valuation metrics.
Growth Score
WeakBENEW faces weak or negative growth trends.
Financial Health Score
ModerateBENEW shows balanced financial health with some risks.
Profitability Score
WeakBENEW struggles to sustain strong margins.
Key Financial Metrics
Is BENEW Expensive or Cheap?
P/E Ratio
BENEW trades at 26.87 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, BENEW's PEG of 0.27 indicates potential undervaluation.
Price to Book
The market values Benessere Capital Acquisition Corp. at -13967.56 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.00 times EBITDA. This is generally considered low.
How Well Does BENEW Make Money?
Net Profit Margin
For every $100 in sales, Benessere Capital Acquisition Corp. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-486.25 in profit for every $100 of shareholder equity.
ROA
Benessere Capital Acquisition Corp. generates $26302.15 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.07 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.87
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.27
vs 25 benchmark
P/B Ratio
Price to book value ratio
-13967.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-486.25
vs 25 benchmark
ROA
Return on assets percentage
26302.15
vs 25 benchmark
ROCE
Return on capital employed
2546.84
vs 25 benchmark
How BENEW Stacks Against Its Sector Peers
| Metric | BENEW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.87 | 18.66 | Worse (Expensive) |
| ROE | -48625.22% | 804.00% | Weak |
| Net Margin | 0.00% | 2258.00% | Weak |
| Debt/Equity | 0.00 | 1.03 | Strong (Low Leverage) |
| Current Ratio | 0.18 | 662.03 | Weak Liquidity |
| ROA | 2630215.43% | -24049.00% (disorted) | Strong |
BENEW outperforms its industry in 2 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Benessere Capital Acquisition Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical